Clinical Trials Logo

Clinical Trial Summary

Inhalants, which are neurotoxic central nervous system (CNS) suppressants, are frequently abused by young adults. Unlike other CNS depressants, including alcohol and opiates, no treatment is currently approved for inhalants dependence. In this report, a novel approach of substitution treatment for inhalants addiction was explored in a double-blinded, randomized, controlled crossover design to examine the effects of inhalation of essential oil (EO) and perfume (PF) on the reduction of cue-induced craving for inhalants in a cohort of thirty-four Thai males with inhalants dependence. The craving response was measured by the modified version of Penn Alcohol Craving Score for Inhalants (PACS-inhalants)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03296943
Study type Interventional
Source Chulalongkorn University
Contact
Status Completed
Phase Phase 3
Start date July 1, 2010
Completion date November 30, 2010